Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Sheng Wang

Showing results (231-240 of 429) with videos related to

Pageof 43
Sort By:
AIDS (London, England)|August 9, 2013
Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patientsZheng Zhang, Junliang Fu, Xiangsheng Xu, et al.
Stem Cells Translational Medicine|November 28, 2017
A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft RejectionMing Shi, Zhenwen Liu, Ying Wang, et al.
Emerging Microbes & Infections|February 23, 2021
High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort studyJiaye Liu, Yuying Hou, Liqin Sun, et al.
World Journal of Gastroenterology|April 8, 2004
Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinomaMing Shi, Bing Zhang, Zi-Rong Tang, et al.
Clinical Immunology (Orlando, Fla.)|October 1, 2008
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patientsLun Cai, Zheng Zhang, Lin Zhou, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitmentJuanjuan Zhao, Zheng Zhang, Yan Luan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2012
Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapyFubiao Kang, Weiwei Chen, Xinwei Zhang, et al.
Viruses|July 27, 2024
T-Cell Epitope Mapping of SARS-CoV-2 Reveals Coordinated IFN-γ Production and Clonal Expansion of T Cells Facilitates Recovery from COVID-19Xing Fan, Jin-Wen Song, Wen-Jing Cao, et al.
Immunology|November 20, 2008
The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressorsYanmei Jiao, JunLiang Fu, Shaojun Xing, et al.
Journal of Natural Products|September 25, 2004
Diterpenoids from Isodon melissoidesAi-Hua Zhao, Quan-Bin Han, Rong-Tao Li, et al.
Pageof 43

Showing results (231-240 of 429) with videos related to

Sort By:
Pageof 43
AIDS (London, England)|August 9, 2013
Safety and immunological responses to human mesenchymal stem cell therapy in difficult-to-treat HIV-1-infected patientsZheng Zhang, Junliang Fu, Xiangsheng Xu, et al.
Stem Cells Translational Medicine|November 28, 2017
A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft RejectionMing Shi, Zhenwen Liu, Ying Wang, et al.
Emerging Microbes & Infections|February 23, 2021
High population-attributable fractions of traditional risk factors for non-AIDS-defining diseases among people living with HIV in China: a cohort studyJiaye Liu, Yuying Hou, Liqin Sun, et al.
World Journal of Gastroenterology|April 8, 2004
Autologous cytokine-induced killer cell therapy in clinical trial phase I is safe in patients with primary hepatocellular carcinomaMing Shi, Bing Zhang, Zi-Rong Tang, et al.
Clinical Immunology (Orlando, Fla.)|October 1, 2008
Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patientsLun Cai, Zheng Zhang, Lin Zhou, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitmentJuanjuan Zhao, Zheng Zhang, Yan Luan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2012
Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapyFubiao Kang, Weiwei Chen, Xinwei Zhang, et al.
Viruses|July 27, 2024
T-Cell Epitope Mapping of SARS-CoV-2 Reveals Coordinated IFN-γ Production and Clonal Expansion of T Cells Facilitates Recovery from COVID-19Xing Fan, Jin-Wen Song, Wen-Jing Cao, et al.
Immunology|November 20, 2008
The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressorsYanmei Jiao, JunLiang Fu, Shaojun Xing, et al.
Journal of Natural Products|September 25, 2004
Diterpenoids from Isodon melissoidesAi-Hua Zhao, Quan-Bin Han, Rong-Tao Li, et al.
Pageof 43